Top Biotech Companies by Market Cap
The definitive ranking of the world's largest publicly traded biotech companies.
Showing928 companies
Total market cap$9.0T
Updated daily
| # | Company | Country | Market Cap | 1D Change |
|---|---|---|---|---|
| 1 |  Eli LillyLLY | United States | $851.4B | -1.22% |
| 2 |  Johnson & JohnsonJNJ | United States | $534.2B | -0.94% |
| 3 |  AbbVieABBV | United States | $355.2B | -1.13% |
| 4 |  AstraZenecaAZN | United Kingdom | $282.1B | -1.30% |
| 5 |  NovartisNVS | Switzerland | $278.1B | -2.00% |
| 6 |  RocheROG.SW | Switzerland | $219.3B | -1.12% |
| 7 |  Novo NordiskNVO | Denmark | $201.3B | +0.09% |
| 8 |  AmgenAMGN | United States | $177.9B | -0.61% |
| 9 |  Shield TherapeuticsSTX | Switzerland | $177.8B | -2.54% |
| 10 |  PPDTMO | United States | $170.5B | +0.32% |
| 11 |  Alliance PharmaceuticalsAPH | United Kingdom | $165.6B | -1.34% |
| 12 |  GileadGILD | United States | $163.2B | -1.64% |
| 13 |  Intuitive SurgicalISRG | United States | $159.2B | +0.39% |
| 14 |  AbbottABT | Ireland | $149.2B | +0.82% |
| 15 |  PfizerPFE | United States | $147.6B | -0.19% |
| 16 |  Danaher CorporationDHR | United States | $121.7B | +0.42% |
| 17 |  Bristol Myers SquibbBMY | United States | $114.0B | -0.60% |
| 18 |  StrykerSYK | United States | $111.1B | +0.65% |
| 19 |  Vertex PharmaceuticalsVRTX | United States | $108.9B | -0.62% |
| 20 |  SanofiSNY | France | $102.8B | -1.35% |
| 21 |  GSK plcGSK | United Kingdom | $100.7B | -0.06% |
| 22 |  MedtronicMDT | Ireland | $98.7B | +0.46% |
| 23 |  Chugai Pharmaceutical4519.T | Japan | $83.1B | -2.41% |
| 24 |  Boston ScientificBSX | Ireland | $82.3B | +1.02% |
| 25 |  RegeneronREGN | United States | $74.6B | -1.66% |
| 26 |  TE ConnectivityTEL | Ireland | $61.5B | -2.83% |
| 27 |  ReichertAME | United States | $53.9B | -2.75% |
| 28 |  UCBUCB.VI | Belgium | $52.5B | +0.99% |
| 29 |  TakedaTAK | United States | $52.3B | -0.48% |
| 30 |  Jiangsu Hengrui Medicine600276.SS | China | $51.5B | +0.09% |
| 31 |  Galderma GroupGALD.SW | Switzerland | $50.1B | -2.02% |
| 32 |  ArgenxARGX | Netherlands | $49.0B | -2.51% |
| 33 |  Sun PharmaceuticalSUNPHARMA.NS | India | $46.9B | -0.85% |
| 34 |  Edwards LifesciencesEW | United States | $46.8B | -0.53% |
| 35 |  Samsung Biologics207940.KS | South Korea | $46.6B | +0.27% |
| 36 |  Siemens HealthineersSHL.DE | Germany | $44.4B | -4.72% |
| 37 |  IDEXX LaboratoriesIDXX | United States | $44.1B | -1.21% |
| 38 |  LonzaLONN.SW | Switzerland | $43.5B | -1.50% |
| 39 |  BayerBAYN.DE | Germany | $43.2B | -2.80% |
| 40 |  Becton DickinsonBDX | United States | $42.7B | +5.87% |
| 41 |  Teva Pharmaceutical IndustriesTEVA | Israel | $41.8B | -0.91% |
| 42 |  CSLCSL.AX | Australia | $41.6B | -1.74% |
| 43 |  Alnylam PharmaceuticalsALNY | United States | $39.9B | -2.34% |
| 44 |  ReponexPEG | Denmark | $38.6B | -1.92% |
| 45 |  SandozSDZNY | Austria | $37.5B | -2.13% |
| 46 | Sandoz GroupSDZ.SW | Switzerland | $37.5B | -1.28% |
| 47 |  Otsuka Holdings4578.T | Japan | $37.1B | -2.09% |
| 48 |  ZoetisZTS | United States | $35.4B | -21.50% |
| 49 |  WatersWAT | United States | $33.8B | +0.27% |
| 50 |  BeOne MedicinesONC | United States | $32.9B | +1.17% |
Showing 1–50 of 928 companies
Page 1 of 19